BECKMAN COULTER LIFE SCIENCES LAUNCHES NEXT-GENERATION BIOLECTOR XT MICROBIOREACTOR

m2p-labs, BioLector family of products acquired by Beckman Coulter Life Sciences in 2020

BAESWEILER, GERMANY (May 25, 2021) – Microbioreactor technology is accelerating and increasing automation capabilities with the launch of the new...

Read more

Beckman Coulter Life Sciences signed a definitive agreement to acquire m2p-labs, a privately held, microbioreactor manufacturer based in Baesweiler,...

Read more

The U.S. government will pay as much as $1.5 billion to buy 100 million doses of Moderna's experimental coronavirus vaccine, securing supplies of a...

Read more

Curevac and car maker Tesla claim their development RNA production tech is less labour intensive and more deployable than alternatives.

 

Read more

The Trump administration has picked five COVID-19 vaccine candidates that it views as the most likely to be successful, according to an article...

Read more

The company said a test in 8 healthy volunteers found its experimental vaccine was safe and provoked a strong immune response. It is on an accelerated...

Read more